Exercisability of Warrants. The Warrants shall be exercisable at any time from October 1, 2006, until 5:30 p.m., New York time, on September 30, 2008.
Exercisability of Warrants. The Warrants shall be immediately exercisable.
Exercisability of Warrants. The Warrants shall be exercisable at any time until 5:30 p.m., New York time, on February 19, 2003.
Exercisability of Warrants. The Warrants shall be exercisable at any time commencing six months after the Effective Date, until 5:30 p.m., New York time, five (5) years after the Effective Date.
Exercisability of Warrants. The Warrants will be exercisable immediately and will expire five years from the original issuance date. Public offering price: $1,000.00 per share of Preferred Stock and related Warrant Underwriting discount: $70.00 per share of Preferred Stock and related Warrant Expected net proceeds: Approximately $[●] million (after deducting the underwriting discount and estimated offering expenses payable by the Company). Trade date: _________, 2016 Settlement date: _________, 2016 Underwriters: Rxxx Capital Partners, LLC [ ] 1 To be revised as necessary SCHEDULE III
Exercisability of Warrants. Each Warrant may be exercised at any time on or after the date hereof, but not after 5:00 P.M., New York City time, on the fifth anniversary of the date hereof (the "Exercise Deadline"). The minimum number of shares of Common Stock with respect to which the Warrants may be exercised as to any holder shall be the lesser of (i) 25,000 and (ii) the number of shares of Common Stock issuable upon exercise of all Warrants held by such holder.
Exercisability of Warrants. The Warrants will be immediately exercisable and will expire five years from the original issuance date Public offering price: $[●] per share of Common Stock and related Warrant Underwriting discount: $[●] per share of Common Stock and related Warrant Overallotment option: Up to an additional [●] shares at a price of $[●] per share and/or Warrants to purchase up to [●]shares of Common Stock at a price of $[●] for each Warrant to purchase one share of Common Stock Expected net proceeds: Approximately $[●] million ($[●] if the overallotment option is exercised in full) (after deducting the underwriting discount and estimated offering expenses payable by the Company) Trade date: June [●], 2016 Settlement date: June [●], 2016 Underwriters: Xxxx Capital Partners, LLC, Xxxxxxx & Company (UK) Ltd. SCHEDULE III List of officers, directors and stockholders executing lock-up agreements J. Xxxxx Xxxxxx Xxxxxxx X. Xxxxx Xxxxxxx X. Xxxxxxxxx Xxxxxx X. Xxxxxxx Xxxxxx X. Xxxxxxxxxx, M.D. Xxxx X. Xxxxx Xxxxxxx X. Xxxxxxx, M.D., Ph.D. Xxxxxx X. Xxxxxxx Xxxxxxx X. Xxxxxx, CMA, MBA Xxxx X. Xxxxxxx, Ph.D. Xxxx Xxxxxxx, M.D., MBA EXHIBIT A Form of Lock-Up Agreement June [●], 2016 Xxxx Capital Partners, LLC 000 Xxx Xxxxxxxx Xxxxx Xxxxxxx Xxxxx, XX 00000 Ladies and Gentlemen: The undersigned understands that you, as the representative (the “Representative”) of the several underwriters named therein, propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with MabVax Therapeutics Holdings, Inc., a Delaware corporation (the “Company”), relating to a proposed offering of securities of the Company (the “Offering”) including shares of the Common Stock, par value $0.01 per share (the “Common Stock”) and warrants to purchase shares of Common Stock. Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting Agreement. In consideration of the foregoing, and in order to induce you to participate the Offering, and for other good and valuable consideration receipt of which is hereby acknowledged, the undersigned hereby agrees that, without the prior written consent of the Representative (which consent may be withheld in its sole discretion), the undersigned will not, during the period (the “Lock-Up Period”) beginning on the date hereof and ending on the date 90 days after the date of the final prospectus relating to the Offering (the “Final Prospectus”), (1) offer, pledge, announce the intention to sell, sell, contrac...
Exercisability of Warrants. The Warrants shall be exercisable at any -------------------------- time from [ ], 1998, until 5:30 p.m., New York time, on [ ], 2002.
Exercisability of Warrants. The Warrant Certificate shall expire if and to the extent the Warrant Shares are not exercised by May 29, 2021 (“Expiration Date”).
Exercisability of Warrants. Each Warrant may be immediately exercised at any time after the Original Issue Date but not after 5:00 p.m., New York time, on October 27, 1999 (the "Expiration Date," which term shall also mean the latest time and date at which the Warrants may be exercised). From and after the Expiration Date, each Warrant not theretofore exercised shall be void and of no effect, and all rights thereunder, and all rights in respect thereof under this Agreement, shall thereupon cease. The Company has secured the effective registration of the shares of Common Stock issuable upon exercise of the Warrants under the Securities Act of 1933, as amended (the "Securities Act"), and has registered or qualified such shares under applicable state securities laws, as requested by the Representative. The Company agrees to use reasonable good faith efforts to maintain such registration and/or qualification in effect and to keep available for delivery upon the exercise of Warrants a prospectus that meets the requirements of section 10 of the Securities Act, until the earlier of the date by which all of the Warrants are exercised or the Expiration Date; provided, however, that the Company shall have no obligation to maintain the effectiveness of such registration or qualification or to keep available a prospectus, as aforesaid, at any time at which such registration or qualification or the delivery of such prospectus is not then required; and provided further, that in the event, by amendment to the Securities Act or otherwise, some other or different requirement shall be imposed by act of Congress of the United States which shall relate to the issuance of Common Stock upon exercise of the Warrants, the Company shall use reasonable good faith efforts to comply with such requirement so long as the same shall not be substantially more burdensome to the Company than the registration requirements under the Securities Act.
